Showing 1 - 12 results of 12 for search 'Yong‐Yu Liu', query time: 0.05s Refine Results
  1. 1
    N6‐methyladenosine‐RNA methylation promotes expression of solute carrier family 7 member 11, an uptake transporter of cystine for lipid reactive oxygen species scavenger glutathione synthesis, leading to hepatoblastoma ferroptosis resistance

    N6‐methyladenosine‐RNA methylation promotes expression of solute carrier family 7 member 11, an uptake transporter of cystine for lipid reactive oxygen species scavenger glutathion... by Ronald A. Hill, Yong‐Yu Liu

    Published 2022-05-01
    Get full text
    Article
  2. 2
    Oligonucleotides blocking glucosylceramide synthase expression selectively reverse drug resistance in cancer cells

    Oligonucleotides blocking glucosylceramide synthase expression selectively reverse drug resistance in cancer cells by Yong-Yu Liu, Tie Yan Han, Jing Yuan Yu, Arie Bitterman, Ahn Le, Armando E. Giuliano, Myles C. Cabot

    Published 2004-05-01
    Get full text
    Article
  3. 3
    Effect of B7.1 costimulation on T-cell based immunity against TAP-negative cancer can be facilitated by TAP1 expression.

    Effect of B7.1 costimulation on T-cell based immunity against TAP-negative cancer can be facilitated by TAP1 expression. by Xiao-Lin Li, Yong-Yu Liu, David Knight, Yoshinobu Odaka, J Michael Mathis, Runhua Shi, Jonathan Glass, Qian-Jin Zhang

    Published 2009-07-01
    Get full text
    Article
  4. 4
    Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models.

    Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models. by Mohamed R Akl, Nehad M Ayoub, Mohamed M Mohyeldin, Belnaser A Busnena, Ahmed I Foudah, Yong-Yu Liu, Khalid A Ei Sayed

    Published 2014-01-01
    Get full text
    Article
  5. 5
    Incorporation of Fluorescence Ceramide-Based HPLC Assay for Rapidly and Efficiently Assessing Glucosylceramide Synthase In Vivo

    Incorporation of Fluorescence Ceramide-Based HPLC Assay for Rapidly and Efficiently Assessing Glucosylceramide Synthase In Vivo by Sachin K. Khiste, Salman B. Hosain, Yixuan Dong, Mohammad B. Uddin, Kartik R. Roy, Ronald A. Hill, Zhijun Liu, Yong-Yu Liu

    Published 2017-06-01
    Get full text
    Article
  6. 6
    Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy

    Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy by Jean Christopher Chamcheu, Tithi Roy, Mohammad Burhan Uddin, Sergette Banang-Mbeumi, Roxane-Cherille N. Chamcheu, Anthony L. Walker, Yong-Yu Liu, Shile Huang

    Published 2019-07-01
    Get full text
    Article
  7. 7
    Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway.

    Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway. by Cheng-Liang Yang, Yong-Yu Liu, Ye-Gang Ma, Yi-Xue Xue, De-Gui Liu, Yi Ren, Xiao-Bai Liu, Yao Li, Zhen Li

    Published 2012-01-01
    Get full text
    Article
  8. 8
    Gb3‐cSrc complex in glycosphingolipid‐enriched microdomains contributes to the expression of p53 mutant protein and cancer drug resistance via β‐catenin–activated RNA methylation

    Gb3‐cSrc complex in glycosphingolipid‐enriched microdomains contributes to the expression of p53 mutant protein and cancer drug resistance via β‐catenin–activated RNA methylation... by Kartik R. Roy, Mohammad B. Uddin, Sagor C. Roy, Ronald A. Hill, John Marshall, Yu‐Teh Li, Jean Christopher Chamcheu, Hua Lu, Yong‐Yu Liu

    Published 2020-11-01
    Get full text
    Article
  9. 9
    A new mixed-backbone oligonucleotide against glucosylceramide synthase sensitizes multidrug-resistant tumors to apoptosis.

    A new mixed-backbone oligonucleotide against glucosylceramide synthase sensitizes multidrug-resistant tumors to apoptosis. by Gauri A Patwardhan, Qian-Jin Zhang, Dongmei Yin, Vineet Gupta, Jianxiong Bao, Can E Senkal, Besim Ogretmen, Myles C Cabot, Girish V Shah, Paul W Sylvester, S Michal Jazwinski, Yong-Yu Liu

    Published 2009-09-01
    Get full text
    Article
  10. 10
    Limited density of an antigen presented by RMA-S cells requires B7-1/CD28 signaling to enhance T-cell immunity at the effector phase.

    Limited density of an antigen presented by RMA-S cells requires B7-1/CD28 signaling to enhance T-cell immunity at the effector phase. by Xiao-Lin Li, Marjolein Sluijter, Elien M Doorduijn, Shubha P Kale, Harris McFerrin, Yong-Yu Liu, Yan Li, Madhusoodanan Mottamal, Xin Yao, Fengkun Du, Baihan Gu, Kim Hoang, Yen H Nguyen, Nichelle Taylor, Chelsea R Stephens, Thorbald van Hall, Qian-Jin Zhang

    Published 2014-01-01
    Get full text
    Article
  11. 11
    Genomic signatures define three subtypes of EGFR-mutant stage II–III non-small-cell lung cancer with distinct adjuvant therapy outcomes

    Genomic signatures define three subtypes of EGFR-mutant stage II–III non-small-cell lung cancer with distinct adjuvant therapy outcomes by Si-Yang Liu, Hua Bao, Qun Wang, Wei-Min Mao, Yedan Chen, Xiaoling Tong, Song-Tao Xu, Lin Wu, Yu-Cheng Wei, Yong-Yu Liu, Chun Chen, Ying Cheng, Rong Yin, Fan Yang, Sheng-Xiang Ren, Xiao-Fei Li, Jian Li, Cheng Huang, Zhi-Dong Liu, Shun Xu, Ke-Neng Chen, Shi-Dong Xu, Lun-Xu Liu, Ping Yu, Bu-Hai Wang, Hai-Tao Ma, Hong-Hong Yan, Song Dong, Xu-Chao Zhang, Jian Su, Jin-Ji Yang, Xue-Ning Yang, Qing Zhou, Xue Wu, Yang Shao, Wen-Zhao Zhong, Yi-Long Wu

    Published 2021-11-01
    Get full text
    Article
  12. 12
    Real-World Survival Outcomes Based on EGFR Mutation Status in Chinese Patients With Lung Adenocarcinoma After Complete Resection: Results From the ICAN Study

    Real-World Survival Outcomes Based on EGFR Mutation Status in Chinese Patients With Lung Adenocarcinoma After Complete Resection: Results From the ICAN Study by Xue-Ning Yang, MD, Hong-Hong Yan, MSc, Jun Wang, MD, Xiang-Yang Chu, MD, Zhi-Dong Liu, MD, Yi Shen, MD, Hai-Tao Ma, MD, Xiang-Ning Fu, MD, Jian Hu, MD, Nai-Kang Zhou, MD, Yong-Yu Liu, MD, Xin-Ming Zhou, MD, Jing-Song Li, MD, Kang Yang, MD, Jian Li, MD, Lin Xu, MD, Si-Yu Wang, MD, Qun Wang, MD, Lun-Xu Liu, MD, Shun Xu, MD, Zhong-Yuan Chen, MD, Hong-He Lou, MD, Chang-Li Wang, MD, Ying Cheng, MD, Si-Yang Liu, MD, Xu-Chao Zhang, MD, Wen-Zhao Zhong, MD, Yi-Long Wu, MD

    Published 2022-01-01
    Get full text
    Article

Search Tools: